A new Deloitte Canada survey of senior leaders finds Canadian organizations are seeing measurable returns from AI, but many may be limiting its long-term impact by focusing on the most visible gains ...
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary Diffusphere technology designed to optimize local, controlled drug delivery for applications with ...
AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability ...
Hypercharge Reports Full Year Fiscal 2026 Results, Record Service and Subscription Revenue and Gross Profit Record Revenue of $10.9 Million , +9% Year-over-Year Record Gross Profit of $3.0 Million , ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results